IMIDomics - Crunchbase Company Profile & Funding

Q: Where is IMIDomics's headquarters?

IMIDomics is located in Barcelona, Catalonia, Spain.

Q: Who invested in IMIDomics?

IMIDomics has 6 investors including Union Chimique Belge And Evotec.

Q: When was the last funding round for IMIDomics?

IMIDomics closed its last funding round on obfuscated from a Corporate Round round.

Q: How much funding has IMIDomics raised to date?

IMIDomics has raised obfuscated.

Overview

IMIDomics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About IMIDomics

CB Rank

59443

IMIDomics is a unique company tackling Immune-Mediated Inflammatory Diseases (IMIDs).

Founded

obfuscation

Private

Corporate Round

Barcelona, Catalonia, Spain

11-50

www.imidomics.com

Biotechnology

Health Care

Funding Rounds

Corporate Round

OBF

obfuscation

Corporate Round

OBF

obfuscation

Series A

OBF

obfuscation

Key People

SARA MARSAL: FOUNDER AND CHIEF MEDICAL OFFICER
Manuel López-Figueroa: Chief Operating Officer
Past Role: Bay City Capital, Managing Director

Details

Legal Name

IMIDomics S.L.

Operating Status

Active

Company Type

For Profit

Founders

Juan Harrison, Manuel López-Figueroa, RICHARD M. MYERS, SARA MARSAL, Susan Vuong, Toni Julià

About the Company

IMIDomics is a unique company tackling Immune-Mediated Inflammatory Diseases (IMIDs). As an innovative leader in discovery and application of biomarkers and new targets to monitor and cure IMIDs, we create value through the combination of the world's largest IMID biobank, extensive relevant clinical expertise, high-throughput genomic and

genetic analysis, and intellectual property. IMIDomics is located at Vall d'Hebron Hospital in Barcelona, Spain and on the HudsonAlpha Institute campus in Huntsville, Alabama.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

IMIDomics Clinical Discovery Engine™

A data-driven platform that integrates comprehensive clinical and biomolecular patient data to identify drug targets and patient stratification markers for immune-mediated inflammatory diseases.

IMIDomics IMID-Biobank

A biobank containing over one million biological specimens from IMID patients and controls, supporting research and drug development for immune-mediated inflammatory diseases.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - IMIDomics	1	obfuscated obfuscation	Union Chimique Belge	Corporate Round
obfuscated obfuscation	Corporate Round - IMIDomics	1	obfuscated obfuscation	Union Chimique Belge	Corporate Round
obfuscated obfuscation	Corporate Round - IMIDomics	1	obfuscated obfuscation	Union Chimique Belge	Corporate Round
obfuscated obfuscation	Corporate Round - IMIDomics	1	obfuscated obfuscation	Union Chimique Belge	Corporate Round
obfuscated obfuscation	Corporate Round - IMIDomics	1	obfuscated obfuscation	Union Chimique Belge	Corporate Round

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - IMIDomics	1	obfuscated obfuscation	Union Chimique Belge	Corporate Round
obfuscated obfuscation	Corporate Round - IMIDomics	1	obfuscated obfuscation	Union Chimique Belge	Corporate Round
obfuscated obfuscation	Corporate Round - IMIDomics	1	obfuscated obfuscation	Union Chimique Belge	Corporate Round
obfuscated obfuscation	Corporate Round - IMIDomics	1	obfuscated obfuscation	Union Chimique Belge	Corporate Round
obfuscated obfuscation	Corporate Round - IMIDomics	1	obfuscated obfuscation	Union Chimique Belge	Corporate Round

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Union Chimique Belge	Yes	Corporate Round - IMIDomics	—
Union Chimique Belge	Yes	Corporate Round - IMIDomics	—
Union Chimique Belge	Yes	Corporate Round - IMIDomics	—
Union Chimique Belge	Yes	Corporate Round - IMIDomics	—
Union Chimique Belge	Yes	Corporate Round - IMIDomics	—